Trityl Irbesartan CAS 138402-10-5 Tsarkake>98.0% (HPLC) Irbesartan Intermediate Factory

Takaitaccen Bayani:

Sunan Chemical: Tril Irbesartan

Synonyms: Triphenyl Irbesartan

Saukewa: 138402-10-5

Tsafta:> 98.0% (HPLC)

Bayyanar: Fari zuwa Kashe-Farin Foda

Matsakaici na Irbesartan (CAS: 138402-11-6)

E-Mail: alvin@ruifuchem.com


Cikakken Bayani

Samfura masu dangantaka

Tags samfurin

Bayani:

Abubuwan Sinadarai:

Sunan Sinadari Tril Irbesartan
Makamantu Triphenyl Irbesartan;Irbesartan N1-Trityl Rashin Tsabta;2-Butyl-3-(2'- (2-tryl-2H-tetrazol-5-yl)-[1,1'-biphenyl] -4-yl) methyl) -1,3-diazaspiro[4.4] -1-en-4-daya;2-Butyl-3-[4-[2- (2-tryl-tetrazol-5-yl) phenyl] methyl] -1,3-diazaspiro [4.4] ba-1-en-4-daya
Lambar CAS 138402-10-5
Lambar CAT Saukewa: RF-PI1893
Matsayin Hannun jari A cikin Hannun jari, Ma'aunin samarwa Har zuwa Ton
Tsarin kwayoyin halitta Saukewa: C44H42N6O
Nauyin Kwayoyin Halitta 670.84
Yawan yawa 1.20± 0.10 g/cm3
Wurin Tafasa 834.6 ± 75.0 ℃ a 760 mmHg
Alamar Ruifu Chemical

Ƙayyadaddun bayanai:

Abu Ƙayyadaddun bayanai
Bayyanar Fari zuwa Kashe-Farin Foda
Tsarkake / Hanyar Bincike 98.0% (HPLC)
Asara akan bushewa <1.00%
Ragowa akan Ignition <0.50%
Rashin Tsabtace Guda Daya <1.00%
Jimlar ƙazanta <2.00%
Karfe masu nauyi <20ppm
Infrared Spectrum Yayi daidai da Tsarin
Matsayin Gwaji Matsayin Kasuwanci
Amfani Matsakaici / Rashin Tsabta na Irbesartan (CAS: 138402-11-6)

Kunshin & Ajiya:

Kunshin: Bottle, Aluminum tsare jakar, 25kg / kwali Drum, ko bisa ga abokin ciniki ta bukata

Yanayin Ajiya:Ajiye a cikin kwantena da aka rufe a wuri mai sanyi da bushe;Kare daga haske da danshi

Amfani:

1

FAQ:

Aikace-aikace:

Trityl Irbesartan (CAS: 138402-10-5) matsakaici ne ko ƙazanta na Irbesartan (CAS: 138402-11-6).Irbesartan shine angiotensin II receptor blocker (ARB) wanda aka nuna don: Maganin hauhawar jini, don rage hawan jini.Rage cutar hawan jini yana rage haɗarin haɗarin cututtukan zuciya da marasa mutuwa, da farko bugun jini da raunin zuciya.Jiyya na ciwon sukari nephropathy a cikin marasa lafiya masu fama da hauhawar jini tare da nau'in ciwon sukari na 2, creatinine mai haɓaka, da proteinuria.Sanofi Research ne ya haɓaka Irbesartan (yanzu ɓangaren Sanofi-Aventis).Sanofi-Aventis da Bristol-Myers Squibb ne ke tallata shi tare a ƙarƙashin sunayen kasuwancin Aprovel, Karvea, da Avapro.

Ku rubuta sakonku anan ku aiko mana